Dermatite atopica da moderata a grave – cialissx.com

Abrocitinib is more effective than dupilumab for treatment of moderate-to-severe atopic dermatitis | 2 Minute Medicine

2 Ago, 22

1. Gli endpoint primari combinati alle settimane 2 e 4